Honasa Terminates Fluence Pharma 58% Acquisition

Date: August 25, 2026

Acquisition Termination Update

Honasa Consumer Limited has formally called off its proposed acquisition of 58% equity stake in Fluence Pharma Private Limited. The decision was made on August 25, 2026 at 9:20 am (IST) due to non-fulfilment of closing conditions specified under the Share Purchase Agreement executed between the Company and Fluence Pharma.

This termination follows the Company's earlier communication dated June 23, 2026 regarding the proposed acquisition, which was subject to completion of conditions precedent.

Strategic Outlook

The Company reaffirmed its commitment to its Nutraceutical strategy and stated it will continue to evaluate both organic and inorganic opportunities to build a strong consumer-focused business in this category.